Oriental Rise Holding Limited (NasdaqCM: ORIS), an integrated supplier of tea products in mainland China, today announced the pricing of its initial public offering (the “Offering”) of 1,750,000 ordinary shares at a public offering price of $4 per ordinary share, for total gross proceeds of $7 million, before deducting underwriting discounts and offering expenses. The Offering is being conducted on a firm commitment basis. The ordinary shares are expected to commence trading on Nasdaq Capital Market under the ticker symbol “ORIS” on October 17, 2024.
The Company has granted the underwriter an option, exercisable within 45 days from the date of the underwriting agreement, to purchase up to an additional 262,500 ordinary shares at the public offering price, less underwriting discounts and expenses. The Offering is expected to close on October 18, 2024, subject to customary closing conditions.
The Company intends to use the proceeds from the Offering for: i) settlement of the outstanding amount for the acquisition of the contractual agreement rights of some of its existing tea gardens; ii) establishment and construction of its new production plant; iii) acquisition of new machinery and equipment; and iv) general corporate purposes and working capital.
US Tiger Securities, Inc. is acting as sole book runner for the Offering. The Crone Law Group is acting as counsel to the Company. VCL Law LLP is acting as counsel to the underwriter with respect to the Offering.
A registration statement on Form F-1, as amended (File No. 333-274976), relating to the Offering was previously filed with the Securities and Exchange Commission (“SEC”) by the Company, and subsequently declared effective by the SEC on September 30, 2024. The Offering is being made only by means of a prospectus, forming a part of the registration statement. A final prospectus relating to the Offering will be filed with the SEC and will be available on the SEC’s website at www.sec.gov. Electronic copies of the final prospectus related to the Offering may be obtained, when available, from US Tiger Securities, Inc., 437 Madison Avenue, 27th Floor, New York, New York 10022, or by telephone at +1 646-978-5188.
Before you invest, you should read the final prospectus and other documents the Company has filed or will file with the SEC for more complete information about the Company and the Offering. This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
